Element Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-467,328
Closed -$15.5M 168
2023
Q3
$15.5M Sell
467,328
-278,303
-37% -$9.84M 1.38% 15
2023
Q2
$27.3M Buy
745,631
+38,756
+5% +$1.51M 1.85% 12
2023
Q1
$28.8M Buy
+706,875
New +$30.5M 2.18% 12
2022
Q4
Sell
-106,196
Closed -$4.65M 120
2022
Q3
$4.65M Hold
106,196
2.23% 10
2022
Q2
$5.57M Buy
106,196
+35,399
+50% +$1.8M 2.79% 5
2022
Q1
$3.67M Sell
70,797
-2,438,202
-97% -$127M 1.83% 15
2021
Q4
$148M Buy
+2,508,999
New +$124M 9.53% 1
2019
Q3
Sell
-82,308
Closed -$3.38M 313
2019
Q2
$3.38M Buy
+82,308
New +$3.27M 0.23% 94
2019
Q1
Sell
-47,504
Closed -$1.97M 936
2018
Q4
$1.97M Sell
47,504
-255,533
-84% -$10.6M 0.06% 226
2018
Q3
$12.7M Buy
303,037
+260,790
+617% +$10M 0.25% 84
2018
Q2
$1.45M Sell
42,247
-1,038,488
-96% -$35.5M 0.04% 212
2018
Q1
$36.4M Buy
+1,080,735
New +$37.2M 0.85% 16

Other funds holding PFE

Element Capital Management's PFE Position: Q4 2023 in Review

Element Capital Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 467,328 shares — an estimated $15.5M sold.

Element Capital Management first reported a position in PFE in Q1 2018 and held it in 12 quarters. The position peaked at $148M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Element Capital Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 467,328 Pfizer shares in Q4 2023, an estimated $15.5M.
  • Element Capital Management first reported a position in Pfizer in Q1 2018 and held it in 12 quarters.
  • Element Capital Management's Pfizer position peaked at $148M in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.